By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SomaLogic, which is developing molecular diagnostic tests based on aptamers, and NEC have signed an agreement to explore business opportunities in the life science and healthcare markets, the firms said today.

In addition, NEC has made an equity investment in SomaLogic, though the amount of the investment and other financial terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.